Proteintech supports neuroscientists with BNA travel bursaries

Proteintech and the British Neuroscience Association collaborate to support early-career neuroscientists.


2nd January 2019 – Proteintech Europe has announced a partnership with the British Neuroscience Association to offer four £250 bursaries to early career neuroscientists attending the BNA 2019 Festival of Neuroscience in Dublin.

The collaboration with the British Neuroscience Association to offer the bursaries comes as part of Proteintech’s commitment to supporting early career researchers. Proteintech regularly offers travel grants to talented scientists throughout the year, including awards for the FENS forum and the Society for Neuroscience annual meeting.

 “It’s important to invest in early-career researchers, giving them the opportunity to grow as scientists, make connections, and present their research in the field.”

-          Dr Karolina Szczesna, Proteintech product manager and technical support.

The bursary is open to PhD students and post-docs based at universities or research institutions in the UK. The chosen recipients will each receive a £250 bursary towards the cost of registration, accommodation and travel to the BNA 2019 Festival of Neuroscience being held 14th- 17th April 2019 in Dublin. The entry period begins today and will close on 28th February 2019.

To find out more and apply for a bursary click here.

About the BNA 2019 Festival of Neuroscience

The four-day BNA Festival of Neuroscience is one of the largest neuroscience events in Europe welcoming over 1,500 delegates from all over the world to celebrate and share the latest thinking in neuroscience. The 4th  BNA Festival of Neuroscience will take place in Dublin, Ireland between 14-17th April 2019.

Find out more about the events here: http://meetings.bna.org.uk/bna2019/

About Proteintech

Proteintech is an antibody manufacturer selling directly to scientists and only selling its own products to maintain the highest level of quality control leading to superior reproducibility and lot consistency. With over 2/3 of the human genome completed, Proteintech have a catalog of over 12,000 antibodies against 12,000 targets covering almost complete spectrum of research areas. With its acquisition of Humanzyme, Proteintech now offers the Humankine product line of animal-free human-cell expressed proteins. To view tens of thousands of publications and in-house validation images in WB, IHC, IF, FC, IP, CHIP, Knock-down siRNA using our antibodies and to learn more about Proteintech and their mission to deliver products directly from their bench to the researcher’s bench, please visit  www.ptglab.com.

 

 

Company News

Posted:
2 January, 2019

Share:


Back
to top